|
 Catechol O‑Methyl Transferase (COMT, HEL-S-98n) degrades catecholamines, catecholestrogens and various drugs having a catechol structure. Mutation of COMT is associated with obsessive-compulsive disorder in men, anxiety phenotypes in women, schizophrenia and other. Developing of the COMT inhibitors is a promising area of neuropsychiatric research. Also catechol‐O‐methyltransferase inhibitors are used as adjuvants to the levodopa/AADC inhibitor therapy for Parkinson's disease treatment.
|
|
Read more...
|
|
|
This section contains information on current OTAVAchemicals products and services (downloadable files in PDF format).
|
|
 Enhancer of zeste homolog 2 (EZH2, ENX-1, ENX1, EZH1, EZH2b, KMT6, KMT6A, WVS, WVS2, enhancer of zeste 2 polycomb repressive complex 2 subunit) is a histone-lysine N-methyltransferase. This enzyme plays an important role in histone methylation and, ultimately, transcriptional repression.
Mutation or over-expression of EZH2 has been linked to many forms of cancer, including bladder, uterine, breast, prostate and renal cancers. EZH2 inhibits genes responsible for suppressing of tumor development, and blocking of it activity may slow tumor growth. Therefore, EZH2 is an attractive target for anti-cancer therapy.
|
|
Read more...
|
|
|
 Lysine-specific demethylase 4C (GASC1, KDM4C, JHDM3C, JMJD2C, TDRD14C, bA146B14.1) is a histone demethylase that specifically demethylates 'Lys-9' and 'Lys-36' residues of histone H3, thereby plays a central role in histone modification. Abnormal functioning of this epigenetic factor is associated with different cancers, including breast cancer. Targeted inhibition of GASC1 in cancer opens new avenues for therapeutic development.
|
|
Read more...
|
|
 The COVID-19 pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is a global health emergency. An attractive drug target for this coronavirus is the main protease (3C-like proteinase, 3CLpro, Mpro) because of its essential role in processing the polyproteins that are translated from the viral RNA.
|
|
Read more...
|
|
|
|
|
|
|
Page 4 of 13 |
HOME
Overview
Products & services booklet 2018
